CTMI's staff has many decades of drug development experience. The center is a cGMP facility manufacturing imaging agents and radiotherapeutics for early stage clinical studies in compliance with USP <823> and FDA 21 CFR Part 212 regulations. Combined with Johns Hopkins Medicine's world-class pre-clinical and clinical research facilities, CTMI is the ideal partner for developing novel imaging diagnostic and therapeutic technologies.
CTMI was established to meet the challenges of bringing new imaging agents and therapeutics to market. We can help speed up your pharmaceutical development while also helping to keep costs under control. Located in the heart of the Johns Hopkins School of Medicine's Bayview Campus, the Center can call upon a vast array of scientific and clinical resources from pre-clinical animal models to clinical trial management and regulatory support.
CTMI actively solicits industrial and academic collaborations. As an Academic Research Organization (ARO), we cut across traditional boundaries to help both academic and commercial partners meet their pharmaceutical development goals.
The mission of CTMI is to serve as an Academic Research Organization (ARO) to develop and provide state-of-the-art imaging and therapeutic agents to address unmet medical needs, bringing personalized medicine within the reach of patients
Copyright © 2019 The Johns Hopkins University Center for Translational Molecular Imaging - All Rights Reserved.